Member Info for RuckRover

Btw,
I googled “leading antibody technology companies”
Could it be these.....?

https://www.equitech-bio.com/collections/igg?gclid=EAIaIQobChMIq5b5sfHA5AIVjLHtCh0z7w8tEAAYAyAAEgLTvPD_BwE

TF, yes it was George Best.

C7,
No problem, we’re good!

Crumbs,
Re your 7:34, many thanks, I played it around 7:35 then got caught up in breakfast, watching grandson play cricket and car washing (typical Sunday)

Well worth a watch. What strikes me most is the way Prof Durant gets her point across. Doesn’t hide behind gobbledegook or techno speak but describes in a way the non-scientific can understand. Her explanation of glycans- “they are just sugars, like the ones you put in your tea”
Brilliant!

Ratty,
Lol. Do you know who first said that?

I, you, him, me, they are always necessary to convey correct meaning. I think half the arguments on the boards are due to misinterpretation of unclear posts.

Dracula, he wasn’t saying you. Inan rarely uses personal pronouns so you have to guess what he means. I think he meant “I better explain..”

C7,
"but in 5 trades from 7.60-7.022 we fell 4.52% in the market."

Up 12% one day and down 4.5% the next
I'd take a repeat of that for the next 30 days!

Inan,
"we need that ability of yours to spot that Pfizer only makes 5% profits on "
So now you resort to making things up! Pfizer make between 19 and 26%. I think one year they showed 43% due to carried forward tax.
This is not a topic of discussion so please stop clogging up the board.

C7, I'm sure some are reccing both lol!

Bermuda,
"Your assumption that I try to downplay Scancell is completely wrong and am disappointed that post received 5 recommendations. "
I'm disappointed but not in the least surprised. There appears to be a group of people on this BB who routinely rec whatever garbage comes out of his fingers and keyboard. I presume on occasions the brain is by-passed.

Inan,
"and the fact that Ruck attempts to post for you .."
I would never presume to post on Bermuda's behalf. He is more than capable of debating any topic with you.
When you make completely unfounded statements, I will step in and argue whoever happens to be the target.

Inan,
"the value in discussing this very simple "thread" is zero .. "
Yes I understand that as it shows you haven't anything to back up your statements it has not only zero but a negative value to you.
This is why you wish to curtail it. May I suggest that the best way to curtail it is to refrain from posting further.

Inan,
"No Ruck .. just highlighting how simple your brain works .."
So you argue that Scancell cannot be compared to "every other bio" as it has (in your words):

"Scancell has Patents ..
as such it has its "own Novel Art" ............."

I point out (using my simple mind) that "every other bio" has patents (including VAL!)

You have no answer to that, so you resort to making derogatory remarks.
Anyway, I couldn't find fault with your 14:04 post!
Looking forward to the "first patient dosed" RNS.

Inan
"Ruck ... I bow to your superior knowledge .. spotting that other bio have patents"

So I take it you withdraw your earlier point that Scancell is NOT like "every other bio" and in fact you now concede that the ARE like "every other bio". So your argument against Bermuda is null and void.

I guess the important thing is what we draw from this similarity. Scancell have patents and VAL have patents.
Conclusion: Having patents, in themselves, is no guarantee of financial success lol

“Scancell has Patents .. “

My point exactly, one of the many similarities between Scancell and “every other bio”

....
as are the differences of course.

I would politely suggest that there are more similarities between Scancell and “every other bio” than there are differences.

I also think it useful to be aware of the norms in “every other bio” as these may be useful in understanding Scancell.

Douve,
Total cancer market estimated to be worth USD 161B by 2020.
The cancer markets Scancell are targeting currently (Immunobody, Moditope) USD 36B.
I have a note of USD 2B for Glycans, I'm not sure where I got this from. If Scancell plan to sell some of the glycan technology early, it will be at a big discount since the buyer will be taking on the development cost and risk.
If glycans prove a huge success, this could impact other forms of treatment - including Immunobody and Moditope!
AIMHO

Kowlesi,
Just think about it objectively. GF is obviously NOT Inan.